Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
Authors
Keywords
Statins, Metaanalysis, Randomized controlled trials, Cancer treatment, Prognosis, Non-small cell lung cancer, Observational studies, Clinical trials (cancer treatment)
Journal
PLoS One
Volume 13, Issue 12, Pages e0209486
Publisher
Public Library of Science (PLoS)
Online
2018-12-21
DOI
10.1371/journal.pone.0209486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals
- (2017) Zubing Mei et al. INTERNATIONAL JOURNAL OF CANCER
- Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
- (2017) Michael J. Seckl et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
- (2017) Youngjoo Lee et al. Cancer Research and Treatment
- Statin-Associated Side Effects
- (2016) Paul D. Thompson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Controlled Open-Label Pilot Study of Simvastatin Addition to Whole-Brain Radiation Therapy in Patients With Brain Metastases
- (2016) Manal El-Hamamsy et al. ONCOLOGY RESEARCH
- A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
- (2015) S H Lim et al. BRITISH JOURNAL OF CANCER
- Lipophilic Statins as Anticancer Agents: Molecular Targeted Actions and Proposal in Advanced Gynaecological Malignancies
- (2015) Salvatore Gizzo et al. CURRENT DRUG TARGETS
- Statins are potential anticancerous agents (Review)
- (2015) ABDULLAH K. ALTWAIRGI ONCOLOGY REPORTS
- Simvastatin plus capecitabine–cisplatin versus placebo plus capecitabine–cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study
- (2014) Seung Tae Kim et al. EUROPEAN JOURNAL OF CANCER
- Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
- (2013) Jung Yong Hong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Statin Use and Reduced Cancer-Related Mortality
- (2012) Sune F. Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
- (2011) Marek Hus et al. ANNALS OF HEMATOLOGY
- A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer
- (2011) Ji-Youn Han et al. CLINICAL CANCER RESEARCH
- Inhibition of Ras for cancer treatment: the search continues
- (2011) Antonio T Baines et al. Future Medicinal Chemistry
- The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial
- (2010) Inge R.H.M. Konings et al. EUROPEAN JOURNAL OF CANCER
- Immortal Time Bias in Pharmacoepidemiology
- (2007) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started